Similar articles for PMID: 24533351

Year	Number of Results
1985	1
1991	1
1992	1
1993	3
1994	4
1995	4
1996	1
1997	6
1998	2
1999	6
2000	7
2001	6
2002	2
2004	1
2005	5
2006	2
2007	4
2008	7
2009	5
2010	2
2011	2
2012	4
2013	5
2014	5
2015	4
2016	2
2017	2
2018	1
2019	1
2020	1
2021	2
2024	0

1

Plasma insulin, glucose, IGF-I, IGF-II, and IGFBP-3 and risk of recurrent colorectal adenomas.

Kang M, Peery AF, Locklear C, Galanko JA, Sandler RS, Keku TO. Kang M, et al. J Gastroenterol Hepatol Res. 2013 Apr 14;2(4):531-535. doi: 10.6051/j.issn.2224-3992.2013.02.247. J Gastroenterol Hepatol Res. 2013. PMID: 24533351 Free PMC article.

2

Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas.

Flood A, Mai V, Pfeiffer R, Kahle L, Rosen CJ, Lanza E, Schatzkin A. Flood A, et al. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1493-8. doi: 10.1158/1055-9965.EPI-08-0048. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559566 Free PMC article.

3

Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men.

Teramukai S, Rohan T, Lee KY, Eguchi H, Oda T, Kono S. Teramukai S, et al. Jpn J Cancer Res. 2002 Nov;93(11):1187-94. doi: 10.1111/j.1349-7006.2002.tb01222.x. Jpn J Cancer Res. 2002. PMID: 12460458 Free PMC article.

4

Insulin resistance, apoptosis, and colorectal adenoma risk.

Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT, Sandler RS. Keku TO, et al. Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2076-81. doi: 10.1158/1055-9965.EPI-05-0239. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16172212

5

Circulating insulin-like growth factor II and colorectal adenomas.

Renehan AG, Painter JE, O'Halloran D, Atkin WS, Potten CS, O'Dwyer ST, Shalet SM. Renehan AG, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3402-8. doi: 10.1210/jcem.85.9.6770. J Clin Endocrinol Metab. 2000. PMID: 10999841 Clinical Trial.

6

Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.

Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ. Schoen RE, et al. Gastroenterology. 2005 Aug;129(2):464-75. doi: 10.1016/j.gastro.2005.05.051. Gastroenterology. 2005. PMID: 16083703

7

High-risk colorectal adenomas and serum insulin-like growth factors.

Renehan AG, Painter JE, Atkin WS, Potten CS, Shalet SM, O'Dwyer ST. Renehan AG, et al. Br J Surg. 2001 Jan;88(1):107-13. doi: 10.1046/j.1365-2168.2001.01645.x. Br J Surg. 2001. PMID: 11136321

8

Circulating levels of IGF-1, IGFBP-3, and IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.

Yoon YS, Keum N, Zhang X, Cho E, Giovannucci EL. Yoon YS, et al. Cancer Epidemiol. 2015 Dec;39(6):1026-35. doi: 10.1016/j.canep.2015.09.004. Epub 2015 Sep 19. Cancer Epidemiol. 2015. PMID: 26388613

9

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.

Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE. Giovannucci E, et al. Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):345-9. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10794477

10

[Relationship between insulin resistance, serum VCAM-1, FGF19, IGF-1 and colorectal polyps].

Qin M, Wang HP, Song B, Sun YL, Wang DY, Chen M, Shi HX, Zhang H, Li ZJ. Qin M, et al. Zhonghua Zhong Liu Za Zhi. 2021 May 23;43(5):553-562. doi: 10.3760/cma.j.cn112152-20210219-00146. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34034475 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year